Dabur India Limited hosted an Analyst and Institutional Investor Meet on November 5, 2026, where India Business CEO, Mr. Herjit Bhalla, shared insights into the company’s performance over the last six months and its strategic vision. The presentation covered key focus areas, progress against the three-year vision, and future plans across its portfolio, including premiumization, health and wellness, and operational efficiencies. The meeting also touched upon the company’s financial performance in Q2 FY27.
Dabur India’s Strategic Outlook and Performance Review
Dabur India Limited convened an Analyst and Institutional Investor Meet on November 5, 2026, to discuss its strategic direction and recent performance. Mr. Herjit Bhalla, India Business CEO, presented an overview of the company’s journey, the insights gained over his first 6 months, and an assessment of its performance against the backdrop of a challenging macroeconomic environment. He highlighted Dabur’s rich heritage, strong brand portfolio, and extensive distribution network.
Vision and Key Pillars
The company’s three-year vision, now 18 months into its cycle, focuses on seven key pillars. These include accelerating core brands, premiumizing the portfolio, making bold bets in health and wellness, simplifying the portfolio, enhancing go-to-market strategies, strategic M&A, and building operating efficiencies. Mr. Bhalla provided an assessment of progress on each pillar, noting areas of strength and opportunities for improvement.
Pillar Progress and Focus Areas
- Accelerating Core Brands: Investments are being made to enhance relevance and drive usage, supported by new communication campaigns for brands like Chyawanprash and Odonil.
- Premiumization: The premium portfolio’s contribution has grown to 20%, with a growth rate 4X that of the overall business. Initiatives include premium offerings in honey and new product launches in personal care.
- Health and Wellness: Focus remains on the digestive business and functional beverages, with potential for further growth in this segment.
- Simplification: Efforts are underway to streamline the portfolio, with 6 brands and 350 SKUs already rationalized.
- Project Saksham: The go-to-market strategy has been recalibrated, leading to improved distributor efficiency and enhanced general trade growth.
- Strategic M&A: The company is evaluating opportunities for strategic acquisitions and minority stakes in D2C companies, with a focus on scalable, adjacent categories.
- Operating Efficiencies: Initiatives like Project Samriddhi and IRIS are aimed at driving cost savings and improving efficiencies across the value chain.
Financial Performance and Outlook
The company reported a 11.6% consolidated growth for Q2 FY27, with India FMCG growing at 10.7%. Despite inflationary pressures, particularly in the HPC segment, Dabur managed to deliver a robust PAT. The business is focused on delivering sustainable growth, with strong momentum observed in alternate channels and a return to growth for general trade. The company reiterated its guidance for full-year double-digit growth.
Future Strategy and ‘Ignite’ Mantra
Dabur is initiating a strategic midterm exercise to develop a medium-term vision for a 2031 plan. The company’s mantra for reigniting growth is ‘Ignite,’ focusing on four key areas: accelerating core growth, enhancing execution, building a future-ready portfolio, and securing funding for investments. These priorities aim to drive faster growth, deliver a more premium portfolio, and enhance savings.
Q&A Highlights
During the Q&A session, key topics included the confidence in achieving M&A targets, plans for disruptive products and D2C, strategies for challenging categories like Chyawanprash and juices, and the company’s organizational structure. Mr. Bhalla emphasized a ‘no new category’ approach for M&A, focusing on adjacent fits and right valuations. He also highlighted the nurturing of D2C businesses like Dabur Shop and the potential of the chemist channel for healthcare products.
Source: BSE
